Literature DB >> 32127473

The atomistic level structure for the activated human κ-opioid receptor bound to the full Gi protein and the MP1104 agonist.

Amirhossein Mafi1, Soo-Kyung Kim1, William A Goddard2.   

Abstract

The kappa opioid receptor (κOR) is an important target for pain therapeutics to reduce depression and other harmful side effects of existing medications. The analgesic activity is mediated by κOR signaling through the adenylyl cyclase-inhibitory family of Gi protein. Here, we report the three-dimensional (3D) structure for the active state of human κOR complexed with both heterotrimeric Gi protein and MP1104 agonist. This structure resulted from long molecular dynamics (MD) and metadynamics (metaMD) simulations starting from the 3.1-Å X-ray structure of κOR-MP1104 after replacing the nanobody with the activated Gi protein and from the 3.5-Å cryo-EM structure of μOR-Gi complex after replacing the 168 missing residues. Using MD and metaMD we discovered interactions to the Gi protein with strong anchors to two intracellular loops and transmembrane helix 6 of the κOR. These anchors strengthen the binding, contributing to a contraction in the binding pocket but an expansion in the cytoplasmic region of κOR to accommodate G protein. These remarkable changes in κOR structure reveal that the anchors are essential for activation.

Entities:  

Keywords:  G protein activation; GEnSeMBLE method; biased ligands; metadynamics; pain analgesics

Mesh:

Substances:

Year:  2020        PMID: 32127473      PMCID: PMC7084096          DOI: 10.1073/pnas.1910006117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  53 in total

1.  Mechanism of the receptor-catalyzed activation of heterotrimeric G proteins.

Authors:  William M Oldham; Ned Van Eps; Anita M Preininger; Wayne L Hubbell; Heidi E Hamm
Journal:  Nat Struct Mol Biol       Date:  2006-08-06       Impact factor: 15.369

2.  Transducin-alpha C-terminal peptide binding site consists of C-D and E-F loops of rhodopsin.

Authors:  S Acharya; Y Saad; S S Karnik
Journal:  J Biol Chem       Date:  1997-03-07       Impact factor: 5.157

3.  Structure of an agonist-bound human A2A adenosine receptor.

Authors:  Fei Xu; Huixian Wu; Vsevolod Katritch; Gye Won Han; Kenneth A Jacobson; Zhan-Guo Gao; Vadim Cherezov; Raymond C Stevens
Journal:  Science       Date:  2011-03-10       Impact factor: 47.728

Review 4.  mu-Opposing actions of the kappa-opioid receptor.

Authors:  Z Z Pan
Journal:  Trends Pharmacol Sci       Date:  1998-03       Impact factor: 14.819

5.  The atomistic level structure for the activated human κ-opioid receptor bound to the full Gi protein and the MP1104 agonist.

Authors:  Amirhossein Mafi; Soo-Kyung Kim; William A Goddard
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-03       Impact factor: 11.205

6.  Mapping of effector binding sites of transducin alpha-subunit using G alpha t/G alpha i1 chimeras.

Authors:  N P Skiba; H Bae; H E Hamm
Journal:  J Biol Chem       Date:  1996-01-05       Impact factor: 5.157

7.  Structure-based discovery of opioid analgesics with reduced side effects.

Authors:  Aashish Manglik; Henry Lin; Dipendra K Aryal; John D McCorvy; Daniela Dengler; Gregory Corder; Anat Levit; Ralf C Kling; Viachaslau Bernat; Harald Hübner; Xi-Ping Huang; Maria F Sassano; Patrick M Giguère; Stefan Löber; Grégory Scherrer; Brian K Kobilka; Peter Gmeiner; Bryan L Roth; Brian K Shoichet
Journal:  Nature       Date:  2016-08-17       Impact factor: 49.962

8.  Forcefield_PTM: Ab Initio Charge and AMBER Forcefield Parameters for Frequently Occurring Post-Translational Modifications.

Authors:  George A Khoury; Jeff P Thompson; James Smadbeck; Chris A Kieslich; Christodoulos A Floudas
Journal:  J Chem Theory Comput       Date:  2013-12-10       Impact factor: 6.006

9.  The structural basis of agonist-induced activation in constitutively active rhodopsin.

Authors:  Jörg Standfuss; Patricia C Edwards; Aaron D'Antona; Maikel Fransen; Guifu Xie; Daniel D Oprian; Gebhard F X Schertler
Journal:  Nature       Date:  2011-03-09       Impact factor: 49.962

10.  Crystal structure of the β2 adrenergic receptor-Gs protein complex.

Authors:  Søren G F Rasmussen; Brian T DeVree; Yaozhong Zou; Andrew C Kruse; Ka Young Chung; Tong Sun Kobilka; Foon Sun Thian; Pil Seok Chae; Els Pardon; Diane Calinski; Jesper M Mathiesen; Syed T A Shah; Joseph A Lyons; Martin Caffrey; Samuel H Gellman; Jan Steyaert; Georgios Skiniotis; William I Weis; Roger K Sunahara; Brian K Kobilka
Journal:  Nature       Date:  2011-07-19       Impact factor: 49.962

View more
  13 in total

1.  Mechanism of β-arrestin recruitment by the μ-opioid G protein-coupled receptor.

Authors:  Amirhossein Mafi; Soo-Kyung Kim; William A Goddard
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-29       Impact factor: 11.205

2.  The quest for high-resolution G protein-coupled receptor-G protein structures.

Authors:  Reinhard Grisshammer
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-16       Impact factor: 11.205

3.  The atomistic level structure for the activated human κ-opioid receptor bound to the full Gi protein and the MP1104 agonist.

Authors:  Amirhossein Mafi; Soo-Kyung Kim; William A Goddard
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-03       Impact factor: 11.205

4.  Structures and Agonist Binding Sites of Bitter Taste Receptor TAS2R5 Complexed with Gi Protein and Validated against Experiment.

Authors:  Moon Young Yang; Soo-Kyung Kim; Donghwa Kim; Stephen B Liggett; William A Goddard
Journal:  J Phys Chem Lett       Date:  2021-09-20       Impact factor: 6.888

Review 5.  Mechanism of opioid addiction and its intervention therapy: Focusing on the reward circuitry and mu-opioid receptor.

Authors:  Jia-Jia Zhang; Chang-Geng Song; Ji-Min Dai; Ling Li; Xiang-Min Yang; Zhi-Nan Chen
Journal:  MedComm (2020)       Date:  2022-06-22

6.  Exploring the putative mechanism of allosteric modulations by mixed-action kappa/mu opioid receptor bitopic modulators.

Authors:  Huiqun Wang; Danni Cao; James C Gillespie; Rolando E Mendez; Dana E Selley; Lee-Yuan Liu-Chen; Yan Zhang
Journal:  Future Med Chem       Date:  2021-02-16       Impact factor: 3.808

7.  Effects of N-Substituents on the Functional Activities of Naltrindole Derivatives for the δ Opioid Receptor: Synthesis and Evaluation of Sulfonamide Derivatives.

Authors:  Chiharu Iwamatsu; Daichi Hayakawa; Tomomi Kono; Ayaka Honjo; Saki Ishizaki; Shigeto Hirayama; Hiroaki Gouda; Hideaki Fujii
Journal:  Molecules       Date:  2020-08-20       Impact factor: 4.411

8.  Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors.

Authors:  Thomas T Joseph; Weiming Bu; Wenzhen Lin; Lioudmila Zoubak; Alexei Yeliseev; Renyu Liu; Roderic G Eckenhoff; Grace Brannigan
Journal:  ACS Chem Neurosci       Date:  2021-04-27       Impact factor: 4.418

9.  Identification and characterization of an atypical Gαs-biased β2AR agonist that fails to evoke airway smooth muscle cell tachyphylaxis.

Authors:  Donghwa Kim; Alina Tokmakova; Lauren K Lujan; Hannah R Strzelinski; Nicholas Kim; Maliheh Najari Beidokhti; Marc A Giulianotti; Amirhossein Mafi; Jung-A A Woo; Steven S An; William A Goddard; Stephen B Liggett
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-07       Impact factor: 11.205

Review 10.  Novel Molecular Targets of Antidepressants.

Authors:  Małgorzata Jarończyk; Jarosław Walory
Journal:  Molecules       Date:  2022-01-14       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.